Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 5 (2008), Issue 9 (September)

1. Magnetic resonance imaging of brain in patients with cirrhotic and non-cirrhotic portal hypertension.
   Dig Dis Sci, 53(10): 2793-8. [Abstract] [Full-text]
2. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease.
   Dig Dis Sci, 53(10): 2789-92. [Abstract] [Full-text]
3. A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells.
   Biochem Biophys Res Commun, 375(2): 210-4. [Abstract] [Full-text]
4. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
   Hepatology, 48(3): 792-8. [Abstract] [Full-text]
5. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
   Hepatology, 48(3): 871-7. [Abstract] [Full-text]
6. Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.
   Hepatology, 48(3): 963-77. [Abstract] [Full-text]
7. Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways.
   Hepatology, 48(3): 909-19. [Abstract] [Full-text]
8. Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
   Hepatology, 48(3): 723-31. [Abstract] [Full-text]
9. Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis.
   Hepatology, 48(3): 853-62. [Abstract] [Full-text]
10. Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.
    Hepatology, 48(3): 1002-10. [Abstract] [Full-text]
11. Large (>or=2 cm) non-hypervascular nodules depicted on MRI in the cirrhotic liver: fate and implications.
    Clin Radiol, 63(10): 1121-30. [Abstract] [Full-text]
12. Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.
    BMC Med Genet, 9: 81. [Abstract] [Full-text]
13. Potent antioxidant role of pirfenidone in experimental cirrhosis.
    Eur J Pharmacol, 595(1): 69-77. [Abstract] [Full-text]
14. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis.
    Lab Invest, 88(10): 1068-78. [Abstract] [Full-text]
15. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury.
    Lab Invest, 88(10): 1090-100. [Abstract] [Full-text]
16. Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis.
    Am J Pathol, 173(4): 993-1001. [Abstract] [Full-text]
17. Significance of central perivenulitis in pediatric liver transplantation.
    Am J Surg Pathol, 32(10): 1479-88. [Abstract] [Full-text]

© 2004-2010 Liver Cirrhosis Research Today. All Rights Reserved.